🔎 Trials Near Me

Gara Jalqabaatti › Diffuse Large B-Cell Lymphoma › Montana › Billings

Qorannoo klinikaalii Diffuse Large B-Cell Lymphoma Billings, MT keessatti

Qorannoo 3 Diffuse Large B-Cell Lymphoma f Billings fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma

Namoota walitti qabaa jiraSadarkaa 2
  • Billings Clinic Cancer Center, Billings
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06649812

A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)

Namoota walitti qabaa jiraSadarkaa 2/3
  • St. Vincent Frontier Cancer Center-Research ( Site 0108), Billings
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT05139017

A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)

Namoota walitti qabaa jiraSadarkaa 3
  • Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana ( Site 0178), Billings
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT06717347

Qorannoo Diffuse Large B-Cell Lymphoma magaalota biroo keessatti

Qorannoo biroo Billings keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.